In 2011, the year that subtypes of ANCA-associated vasculitis (AAV) were officially renamed according to key pathological characteristics, important progress was made not only in differentiating these subtypes, but also in understanding—and treating—their eponymous manifestations.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
M2 macrophage is the predominant phenotype in airways inflammatory lesions in patients with granulomatosis with polyangiitis
Arthritis Research & Therapy Open Access 18 May 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Change history
24 January 2012
In the version of this article initially published online, the text "In 2011" was written as "In 2001". The error has been corrected for the print, HTML and PDF versions of the article.
References
Falk, R. J. et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum. 63, 863–864 (2011).
Linder, R. et al. Differentiation between Wegener's granulomatosis and microscopic polyangiitis by an artificial neural network and by traditional methods. J. Rheumatol 38, 1039–1047 (2011).
Schmitt, W. H., Linder, R., Reinhold-Keller, E. & Gross, W. L. Improved differentiation between Churg-Strauss syndrome and Wegener's granulomatosis by an artificial neural network. Arthritis Rheum. 44, 1887–1896 (2001).
Fujimoto, S. et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK. Rheumatology (Oxford) 50, 1916–1920 (2011).
Arning, L. et al. Are there specific genetic risk factors for the different forms of ANCA-associated vasculitis? Ann. Rheum. Dis. 70, 707–708 (2010).
Holle, J. U. et al. Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage? Ann. Rheum. Dis. 69, 1934–1939 (2010).
Holle, J. U. et al. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations. Ann. Rheum. Dis. http://dx.doi.org/10.1136/ard.2011.153601
Holden, N. J. et al. ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process. Ann. Rheum. Dis. 70, 2229–2233 (2010).
Thurner, L. et al. Wegener's granuloma harbour B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspanin. J. Autoimmun. 36, 87–90 (2011).
Laudien, N. et al. Molecular signatures of a disturbed nasal barrier function in the primary tissue of Wegener's granulomatosis. Mucosal Immunol. 4, 564–573 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Gadola, S., Gross, W. The renaissance of granulomatous inflammation in AAV. Nat Rev Rheumatol 8, 74–76 (2012). https://doi.org/10.1038/nrrheum.2011.218
Published:
Issue date:
DOI: https://doi.org/10.1038/nrrheum.2011.218
This article is cited by
-
M2 macrophage is the predominant phenotype in airways inflammatory lesions in patients with granulomatosis with polyangiitis
Arthritis Research & Therapy (2017)
-
Granuloma in ANCA-Associated Vasculitides: Another Reason to Distinguish Between Syndromes?
Current Rheumatology Reports (2013)
-
Advances in Therapy for ANCA-Associated Vasculitis
Current Rheumatology Reports (2012)
